General Practitioners' Felt With Their Patients' Death (REGIDAQ) (REGIDAQ)

January 21, 2019 updated by: University Hospital, Limoges
Very few studies are dealing with the way general practitioners feel the death of their patients. Main studies about that subject are qualitative. It needs quantitative studies to analyse how is felt general practitioners' patients' death. This is an epidemiologic quantitative cross-sectional study. The Studied population is the whole of the general practitioners of the region Nouvelle-Aquitaine. The primary endpoint is the percentage of the general practitioners which have hard time living with their patients' death. The secondary endpoints are to evaluate the general practitioners' help needing after their patients' death, to evaluate the personal and professional impact of the patient's death, the percentage of general practitioners using chemical aid after their patients' death and to determinate the existence of support facilities to help general practitioners to stand patients' death. The results of that study could help general practitioners to improve their medical practice in the patient's death situation.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

481

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Limoges, France, 87042
        • University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

General practitioners from the Nouvelle Aquitaine region

Description

Inclusion Criteria:

  • General practitioners from the Nouvelle-Aquitaine region.
  • Exclusive or joint exercise of general medicine.
  • None retired

Exclusion Criteria:

  • Retired patricians
  • Students, Residents
  • General practitioners from another region
  • General practitioners with no general medicine activity

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
percentage of hard time living
Time Frame: 2 months (End of study)
percentage of general practitioners which have hard time living with their patients' death
2 months (End of study)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
percentage of help needing
Time Frame: 2 months (End of study)
percentage of general practitioners which need help after their patients' death
2 months (End of study)
percentage of personal impact
Time Frame: 2 months (End of study)
percentage of general practitioners which have a personal impact when their patient's death
2 months (End of study)
percentage of professional impact
Time Frame: 2 months (End of study)
percentage of general practitioners witch have a professional impact when the patient's death
2 months (End of study)
percentage of chemical aid using
Time Frame: 2 months (End of study)
percentage of general practitioners using chemical aid after their patients' death
2 months (End of study)
support facilities
Time Frame: 2 months (End of study)
Determinate the existence of support facilities to help general practitioners to stand patients' death
2 months (End of study)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University Hospital, Limoges

Investigators

  • Principal Investigator: Karen Rudelle, doctor, University Hospital, Limoges

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 13, 2018

Primary Completion (Actual)

May 13, 2018

Study Completion (Actual)

May 13, 2018

Study Registration Dates

First Submitted

August 23, 2017

First Submitted That Met QC Criteria

September 1, 2017

First Posted (Actual)

September 5, 2017

Study Record Updates

Last Update Posted (Actual)

January 23, 2019

Last Update Submitted That Met QC Criteria

January 21, 2019

Last Verified

August 1, 2017

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • I16018 (REGIDAQ)

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Death

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Pakistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe